You are here

  • Home
  • Archive
  • Volume 2010, Issue
  • Recurrent oesophageal intramucosal squamous carcinoma treated by endoscopic mucosal resection and subsequent radiofrequency ablation using HALO system

Article Text

Article menu
Download PDFPDF
Novel treatment (new drug/intervention; established drug/procedure in new situation)
Recurrent oesophageal intramucosal squamous carcinoma treated by endoscopic mucosal resection and subsequent radiofrequency ablation using HALO system
  1. Ivana Kajzrlikova1,
  2. Petr Vitek1,
  3. Premysl Falt2,
  4. Ondrej Urban2,
  5. Pavel Kominek3
  1. 1Faculty of Medicine, Ostrava University, Beskydy Gastrocentre, Hospital Frydek-Mistek, Frydek-Mistek, Czech Republic
  2. 2Digestive Diseases Centre, Vitkovice Hospital, Ostrava, Czech Republic
  3. 3Clinic of Otorhinolaryngology, Faculty hospital Ostrava, Ostrava, Czech Republic
  1. Correspondence to Ivana Kajzrlikova, Ivanakaj{at}seznam.cz

Summary

The method of radiofrequency ablation (RFA) is currently used for the treatment of high-grade dysplasia in Barrett's oesophagus. It has theoretical potential also for the use in squamous epithelial neoplasias. The authors present a case report of an early diagnosis of squamous cancer in a high-risk patient, its endoscopic treatment and follow-up, and successful RFA of recurrent neoplasia. RFA can expand our therapeutic possibilities for the management of recurrent neoplastic lesions after endoscopic treatment of squamous oesophageal cancer.

https://doi.org/10.1136/bcr.08.2010.3211

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Competing interests None.

    • Patient consent Obtained.